Literature DB >> 10545041

Cognitive abilities in children with congenital muscular dystrophy: correlation with brain MRI and merosin status.

E Mercuri1, J Gruter-Andrew, J Philpot, C Sewry, S Counsell, S Henderson, A Jensen, I Naom, G Bydder, V Dubowitz, F Muntoni.   

Abstract

The aim of the study was to evaluate whether children with merosin-positive or merosin-deficient congenital muscular dystrophy (CMD) show any cognitive impairment and whether this is related to brain abnormalities on magnetic resonance imaging (MRI). Twenty-two patients (age range: 5.8-15.3 years) were assessed by the Wechsler Intelligence Scales. Twelve were merosin-positive and ten merosin-deficient. One child had severe mental retardation and could not be tested. The full scale IQ in the remaining 21 ranged from 51 to 134, the verbal IQ ranged from 78 to 136 and the performance from 51 to 136. Of the twelve children with normal merosin one had a mild delay (IQ < 75) and two were borderline (IQ 75-95). Of the ten children with merosin-deficiency, one showed severe mental retardation and could not be tested, one showed a mild delay and two had borderline results. While the children with merosin deficiency with the typical diffuse white matter changes on MRI had normal scores, the children who in addition had cerebellar hypoplasia had lower performance IQ. The child with cortical dysplasia had severe mental retardation. Our results suggest that the spectrum of cognitive abilities in CMD is very wide even within genetically homogeneous conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545041     DOI: 10.1016/s0960-8966(99)00034-6

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

Review 1.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

2.  Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI.

Authors:  Claudia C Leite; Leandro T Lucato; Maria G M Martin; Lucio G Ferreira; Maria B D Resende; Mary S Carvalho; Suely K N Marie; J Randy Jinkins; Umbertina C Reed
Journal:  Pediatr Radiol       Date:  2005-03-05

3.  Cobblestone Malformation in LAMA2 Congenital Muscular Dystrophy (MDC1A).

Authors:  Himali Jayakody; Sanam Zarei; Huy Nguyen; Joline Dalton; Kelly Chen; Louanne Hudgins; John Day; Kara Withrow; Arti Pandya; Jean Teasley; William B Dobyns; Katherine D Mathews; Steven A Moore
Journal:  J Neuropathol Exp Neurol       Date:  2020-09-01       Impact factor: 3.685

4.  Cognitive impairment in neuromuscular diseases: A systematic review.

Authors:  Marco Orsini; Ana Carolina; Andorinho de F Ferreira; Anna Carolina Damm de Assis; Thais Magalhães; Silmar Teixeira; Victor Hugo Bastos; Victor Marinho; Thomaz Oliveira; Rossano Fiorelli; Acary Bulle Oliveira; Marcos R G de Freitas
Journal:  Neurol Int       Date:  2018-07-04

5.  Laminin α2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development.

Authors:  Maqsood Ahmed; Leandro N Marziali; Ernest Arenas; M Laura Feltri; Charles Ffrench-Constant
Journal:  Development       Date:  2019-08-29       Impact factor: 6.868

6.  LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort.

Authors:  Alberto A Zambon; Deborah Ridout; Marion Main; Rachael Mein; Rahul Phadke; Francesco Muntoni; Anna Sarkozy
Journal:  Ann Clin Transl Neurol       Date:  2020-09-10       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.